We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Exosomes – News and Features

News

Landmark Publication Reports Potential of Exosomes as Biomarkers for Early Disease Detection

NanoSight reports the new publication in one of the most cited peer reviewed journals in nanoscience and nanotechnology, NanoMedicine.
News

Body Fluid Derived Exosomes as a Novel Template for Clinical Diagnostics

In this paper researchers from the German Cancer Research Center demonstrate how the isolation of exosomes, being a minimally invasive procedure, opens new possibilities for diagnostics.
News

Exosome Diagnostics Announces Expansion of Scientific Advisory Board

Exosome appoints Bob Carter MD, Carlos Cordon-Cardo MD, PhD, Keith Flaherty MD, John Quackenbush, PhD; to its Scientific Advisory Board.
News

Key Genes Associated with Cancer Found in Circulating Blood Microvesicles

A study published in Nature Communications by researchers at Massachusetts General Hospital/Harvard Medical School shows that tumor microvesicles contain retro-transposons, also known as "jumping genes" as well as amplified oncogene sequences. These discoveries expand further on the use of microvesicles such as exosomes as a powerful blood-based cancer diagnostic medium.
News

NanoSight announces interactive webinar on January 27th on Exosome Characterization by Nanoparticle Tracking Analysis

NanoSight, world-leading manufacturers of unique nanoparticle characterization technology, will host an interactive webinar on the subject of exosome characterization by Nanoparticle Tracking Analysis.
News

Conference Highlights Biomarker Detection Role for NanoSight

Oxford researchers presented new data applying NTA to size and count both cellular microvesicles and exosomes at a low concentration.
News

World's Most Comprehensive Nanoparticle System Unveiled at Global Biotech Event

Izon Science will unveil its latest breakthrough in nanoparticle analysis in the US this week.
News

Exosome Diagnostics and DxS Collaborate to Develop Blood Based Tests for Key Cancer Mutations

The collaboration is based on the development of blood based companion diagnostics for key cancer gene mutations.
News

NanoSight to Supply Instrumentation for Wellcome Trust Technology Development Grant

NanoSight’s methodologies aimed at measuring cellular nanoparticles in plasma and urine as biomarkers of a broad range of human disease conditions.
Advertisement